Complicating risk factors for pyelonephritis after extracorporeal shock wave lithotripsy

International Journal of Urology

Volumn 7, Issue 6, 2000, Pages 224-230

  Fujita, Kimio ^a   Mizuno, Takuji ^a   Ushiyama, Tomomi ^a   Suzuki, Kazuo ^a   Hadano, Shinsuke ^a   Satoh, Shigenori ^a   Kambayashi, Tomoyuki ^a   Mugiya, Soichi ^a   Nakano, Masaru ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antimicrobial; Extracorporeal shock wave lithotripsy; Prophylaxis; Pyelonephritis

Indexed keywords

CRAVID; LEVOFLOXACIN;

ADOLESCENT; ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIURIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXTRACORPOREAL LITHOTRIPSY; FEMALE; FEVER; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PHYSICIAN; PRIORITY JOURNAL; PYELONEPHRITIS; PYURIA; RISK FACTOR; URETER OBSTRUCTION; URETER STONE; UROLITHIASIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTI-INFECTIVE AGENTS, URINARY; BACTERIURIA; HUMANS; KIDNEY CALCULI; LITHOTRIPSY; MIDDLE AGED; MULTIVARIATE ANALYSIS; OFLOXACIN; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PYELONEPHRITIS; RISK FACTORS; SEX DISTRIBUTION;

EID: 0034126204     PISSN: 09198172     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-2042.2000.00182.x     Document Type: Article

References (14)

1. 1 Lingeman JE, Newman D, Mertz JHO et al. Extracorporeal shock wave lithotripsy: The Methodist Hospital of Indiana experience. J. Urol. 1986; 135: 1134-7.
2. 2 Libby JM, Meacham RB, Griffith DP. The role of silicone ureteral stents in extracorporeal shock wave lithotripsy of large renal calculi. J. Urol. 1988; 139: 15-17.
3. 3 Fujita K, Sayama T, Matsushima H, Munakata A. Stone burden on extracorporeal shock wave lithotripsy. Jpn J. Urol. 1990; 81: 873-7.
4. 4 Knipper A, Bohle A, Pensel J, Hofstetter AG. Antibiotic prophylaxis with enoxacin in extracorporeal shock wave lithotripsy. J. Infect. 1989; 17(Suppl.): 537-8.
5. 5 Pettersson B, Tiselius H-G. Are prophylactic antibiotics necessary during extracorporeal shockwave lithotripsy? Br. J. Urol. 1989; 63: 449-52.
6. 6 Charton M, Vallancien G, Veillon B, Prapotnich D, Mombert A, Brissert JM. Use of antibiotics in conjunction with extracorporeal lithotripsy. Eur. Urol. 1990; 17: 134-8.
7. 7 Raz R, Zoabi A, Sudarsky M, Shental J. The incidence of urinary tract infection in patients without bacteriuria who underwent extracorporeal shock wave lithotripsy. J. Urol. 1994; 151: 329-30.
8. 8 Fujita K. A score to predict fever following ESWL. Nishinihon J. Urol. 1996; 58: 1-4.
9. 9 Hugosson J, Grenabo L, Hedelin H, Petersson S, Seeberg S. Bacteriology of upper urinary tract stones. J. Urol. 1990; 143: 965-8.
10. 10 Dincel C, Ozdiler E, Ozenci H, Tazici N, Kosar A. Incidence of urinary tract infection in patients without bacteriuria undergoing ESWL: Comparison of stone types. J. Endourol. 1998; 12: 1-3.
11. 11 Silber N, Kremer I, Gaton DD, Servadio C. Severe sepsis following extracorporeal shock wave lithotripsy. J. Urol. 1991; 145: 1045-6.
12. 12 Westh H, Knudsen F, Hedengran AM et al. Extracorporeal shock wave lithotripsy of kidney stones does not induce transient bacteremia. A prospective study. J. Urol. 1990; 144: 15-16.
13. 13 Claes H, Vandeursen R, Baert L. Amoxycillin/ clavulante prophylaxis for extracorporeal shock wave lithotripsy: A comparative study. J. Antimicrob. Chemother. 1989; 24: 217-20.
14. 14 Pode D, Lenkovsky Z, Shapiro A, Pfau A. Can extracorporeal shock wave lithotripsy eradicate persistent urinary infection associated with infected stones? J. Urol. 1988; 40: 257-9.